Episode 278

February 02, 2026

00:19:06

278: Illumina, Grail and FTC scrutiny of vertical mergers in human genetic technologies

Hosted by

Gustavo B Barra
278: Illumina, Grail and FTC scrutiny of vertical mergers in human genetic technologies
Base by Base
278: Illumina, Grail and FTC scrutiny of vertical mergers in human genetic technologies

Feb 02 2026 | 00:19:06

/

Show Notes

Rashid AI et al., The American Journal of Human Genetics - US antitrust shifts in human genetic technologies: FTC scrutiny of Illumina’s acquisition of Grail alters NGS market oversight and could affect spin-offs and startups.

Study Highlights:
This perspective examines the US legal and regulatory landscape for human genetic and genomic technologies, focusing on FTC and DOJ policy changes and enforcement habits. Using a case-study approach centered on Illumina’s proposed acquisition and eventual divestiture of Grail, the authors review updated merger guidelines, non-compete rule developments, and exclusive-dealing concerns. They report that the 2023 merger guidelines lowered thresholds for presumed anti-competitiveness and that the FTC’s challenge emphasized risks to nascent mult-cancer early detection competitors that rely on next-generation sequencing platforms. The authors conclude that heightened vertical-merger scrutiny may reduce spin-offs and early-stage acquisitions, prompting firms to favor in-house R&D or alternate collaboration models.

Conclusion:
Heightened scrutiny of vertical mergers and attention to nascent competition in US antitrust policy is likely to reshape biotechnology strategies by reducing spin-offs and encouraging in-house development.

Music:
Enjoy the music based on this article at the end of the episode.

Reference:
Rashid AI, Rincon NA, Rihani N, Wagner JK. Competition in human genetic technologies: The current US legal landscape. The American Journal of Human Genetics. 2026;113:1–10. https://doi.org/10.1016/j.ajhg.2025.12.012

License:
This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) - https://creativecommons.org/licenses/by/4.0/

Support:
Base by Base – Stripe donations: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00

Official website https://basebybase.com

On PaperCast Base by Base you’ll discover the latest in genomics, functional genomics, structural genomics, and proteomics.

Episode link: https://basebybase.castos.com/episodes/illumina-grail-vertical-mergers

Other Episodes